Recombinant Soluble CD32 Suppresses Disease Progression in Experimental Epidermolysis Bullosa Acquisita

Overview

Journal J Invest Dermatol

Publisher Elsevier

Specialty Dermatology

Date 2014 Oct 21

PMID 25330298

Citations 8

Authors

Hiroaki Iwata

Elena Pipi

Nicole Mockel

Peter Sondermann

Artem Vorobyev

Nina van Beek

Detlef Zillikens

Ralf J Ludwig

Affiliations

Soon will be listed here.

Citing Articles

Epidermolysis Bullosa Acquisita-Current and Emerging Treatments.

Tesanovic Perkovic D, Bukvic Mokos Z, Marinovic B J Clin Med. 2023; 12(3).

PMID: 36769788 PMC: 9917799. DOI: 10.3390/jcm12031139.

Fcγ Receptor IIB Controls Skin Inflammation in an Active Model of Epidermolysis Bullosa Acquisita.

Kovacs B, Tillmann J, Freund L, Nimmerjahn F, Sadik C, Bieber K Front Immunol. 2020; 10:3012.

PMID: 31993051 PMC: 6971089. DOI: 10.3389/fimmu.2019.03012.

Epidermolysis Bullosa Acquisita: The 2019 Update.

Koga H, Prost-Squarcioni C, Iwata H, Jonkman M, Ludwig R, Bieber K Front Med (Lausanne). 2019; 5:362.

PMID: 30687710 PMC: 6335340. DOI: 10.3389/fmed.2018.00362.

Mechanisms of Autoantibody-Induced Pathology.

Ludwig R, Vanhoorelbeke K, Leypoldt F, Kaya Z, Bieber K, McLachlan S Front Immunol. 2017; 8:603.

PMID: 28620373 PMC: 5449453. DOI: 10.3389/fimmu.2017.00603.

Reduced skin blistering in experimental epidermolysis bullosa acquisita after anti-TNF treatment.

Hirose M, Kasprick A, Beltsiou F, Dieckhoff Schulze K, Schulze F, Samavedam U Mol Med. 2016; 22:918-926.

PMID: 27999842 PMC: 5319204. DOI: 10.2119/molmed.2015.00206.

References

Gupta R, Woodley D, Chen M . Epidermolysis bullosa acquisita. Clin Dermatol. 2011; 30(1):60-9. PMC: 3234994. DOI: 10.1016/j.clindermatol.2011.03.011. View

Engineer L, Ahmed A . Emerging treatment for epidermolysis bullosa acquisita. J Am Acad Dermatol. 2001; 44(5):818-28. DOI: 10.1067/mjd.2001.113693. View

Varin N, Sautes C, Galinha A, Even J, Hogarth P, Fridman W . Recombinant soluble receptors for the Fc gamma portion inhibit antibody production in vitro. Eur J Immunol. 1989; 19(12):2263-8. DOI: 10.1002/eji.1830191213. View

McKenzie S, Taylor S, Malladi P, Yuhan H, Cassel D, Chien P . The role of the human Fc receptor Fc gamma RIIA in the immune clearance of platelets: a transgenic mouse model. J Immunol. 1999; 162(7):4311-8. View

Schmidt E, Zillikens D . Pemphigoid diseases. Lancet. 2012; 381(9863):320-32. DOI: 10.1016/S0140-6736(12)61140-4. View

Collin M, Ehlers M . The carbohydrate switch between pathogenic and immunosuppressive antigen-specific antibodies. Exp Dermatol. 2013; 22(8):511-4. DOI: 10.1111/exd.12171. View

Kasperkiewicz M, Nimmerjahn F, Wende S, Hirose M, Iwata H, Jonkman M . Genetic identification and functional validation of FcγRIV as key molecule in autoantibody-induced tissue injury. J Pathol. 2012; 228(1):8-19. DOI: 10.1002/path.4023. View

Ierino F, Powell M, McKenzie I, Hogarth P . Recombinant soluble human Fc gamma RII: production, characterization, and inhibition of the Arthus reaction. J Exp Med. 1993; 178(5):1617-28. PMC: 2191234. DOI: 10.1084/jem.178.5.1617. View

Ludwig R, Kalies K, Kohl J, Zillikens D, Schmidt E . Emerging treatments for pemphigoid diseases. Trends Mol Med. 2013; 19(8):501-12. DOI: 10.1016/j.molmed.2013.06.003. View

10.

Iwata H, Bieber K, Tiburzy B, Chrobok N, Kalies K, Shimizu A . B cells, dendritic cells, and macrophages are required to induce an autoreactive CD4 helper T cell response in experimental epidermolysis bullosa acquisita. J Immunol. 2013; 191(6):2978-88. DOI: 10.4049/jimmunol.1300310. View

11.

Werwitzke S, Trick D, Sondermann P, Kamino K, Schlegelberger B, Kniesch K . Treatment of lupus-prone NZB/NZW F1 mice with recombinant soluble Fc gamma receptor II (CD32). Ann Rheum Dis. 2007; 67(2):154-61. DOI: 10.1136/ard.2006.068981. View

12.

Getahun A, Dahlstrom J, Wernersson S, Heyman B . IgG2a-mediated enhancement of antibody and T cell responses and its relation to inhibitory and activating Fc gamma receptors. J Immunol. 2004; 172(9):5269-76. DOI: 10.4049/jimmunol.172.9.5269. View

13.

Magnusson S, Andren M, Nilsson K, Sondermann P, Jacob U, Kleinau S . Amelioration of collagen-induced arthritis by human recombinant soluble FcgammaRIIb. Clin Immunol. 2008; 127(2):225-33. DOI: 10.1016/j.clim.2008.02.002. View

14.

Woodley D, Burgeson R, Lunstrum G, Bruckner-Tuderman L, Reese M, Briggaman R . Epidermolysis bullosa acquisita antigen is the globular carboxyl terminus of type VII procollagen. J Clin Invest. 1988; 81(3):683-7. PMC: 442515. DOI: 10.1172/JCI113373. View

15.

Kleinau S, Martinsson P, Heyman B . Induction and suppression of collagen-induced arthritis is dependent on distinct fcgamma receptors. J Exp Med. 2000; 191(9):1611-6. PMC: 2213438. DOI: 10.1084/jem.191.9.1611. View